Tavotek Lab

Tavotek Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing innovative multispecific antibodies for oncology and autoimmune diseases. The company utilizes its proprietary technology platforms, including TavoSelect and TavoPrecise, to engineer biologics with enhanced specificity and therapeutic efficacy. Its lead candidate, TAVO412, is a multispecific antibody targeting EGFR, c-Met, and VEGF for the treatment of solid tumors. Tavotek operates research and development facilities in both the United States and China to leverage global expertise in drug discovery. By focusing on complex protein engineering, the company aims to address unmet medical needs in patients with difficult-to-treat cancers and inflammatory conditions.